Growing prevalence of peripheral vascular and coronary artery diseases has fuelled demand for scoring balloon catheter devices in the healthcare sector. Moreover, increasing demand for medical devices equipped with enhanced technology is projected to impact the global market growth of scoring balloon catheter positively. According to a recently published report, the global scoring balloon catheter market will reflect sluggish CAGR growth over the forecast period, 2017 – 2022.
Factors Propelling Global Market Growth
Increasing prevalence of coronary artery diseases has led to an upsurge in demand for scoring balloon catheter devices in the healthcare sector. Healthcare manufacturers prefer scoring balloon catheter devices over the conventional devices for the treatment of the coronary artery diseases attributed to limitations such as uncontrolled dissections including bailout stenting and insufficient luminal expansion.
For detailed insights on enhancing your product footprint, request for a sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=148
Moreover, healthcare professionals prefer using scoring balloon catheter devices over conventional catheter devices for treatment of peripheral vascular diseases. Fibrocalcific lesion is resistant to dialation through conventional balloon catheter devices attributed to inadequate luminal expansion. Due to these factors, manufacturers are adopting scoring technology for the production of the scoring balloon catheter devices in the healthcare sector. These factors are likely to contribute towards the global market growth of scoring balloon catheter positively.
On the other hand, growing risks regarding artery collapse during the catheterization treatment is projected to influence demand for scoring balloon catheter devices negatively. Moreover, increasing risks of infection due to the treatment of catheterization is projected to pose significant challenges for scoring balloon catheter devices in the global market by 2022 – end. These factors are expected to inhibit the global market growth of scoring balloon catheter devices during the projected period.
For critical insights on this market, request for methodology here – https://www.factmr.com/connectus/sample?flag=RM&rep_id=148
Nylon to Represent a Leading Market
Cardiac catheterization laboratories is projected to register a relatively high CAGR among other end users in the global market of scoring balloon catheter through 2022. In revenue terms, hospitals will witness a relatively high growth in the global market by 2022–end. Hospitals in Europe is projected to generate significant revenue globally throughout 2022.
In terms of disease indications, coronary artery disease is projected to represent a relatively high growth in revenue terms in the global market of scoring balloon catheter devices. This segment will witness around US$ 40 Mn in the global market in 2017. Peripheral vascular disease segment is projected to register significant growth after coronary artery disease segment.
For comprehensive insights on this market adoption, ask an analyst here – https://www.factmr.com/connectus/sample?flag=AE&rep_id=148
Nylon among various raw materials is projected to register a relatively high growth in revenue terms throughout 2022. This segment will represent US$ 30 Mn by the end of 2017. Among other regions, North America will witness a major market for the nylon segment globally. Polyurethane is projected to reflect a relatively high CAGR in the global market by 2022 – end.
Key players in the global market of scoring balloon catheter are B. Braun Melsungen AG, Medtronic Plc, Tokai Medical Products Inc., BIOTRONIK SE & Co. KG, Terumo Corporation, Boston Scientific Corporation, Jotech GmbH, MicroPort Scientific Corporation, Hexacath, Meril Life Sciences Pvt Ltd, Cordis Corporation, Abbott Laboratories, Cardionovum GmbH, and Cook Medical INC.
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.
US Sales Office:
11140 Rockville Pike
Rockville, MD 20852
Tel: +1 (628) 251-1583